AmSpa 2027: April 15-18, Wynn Las Vegas
AmSpa's Medical Spa Show returns to the Wynn Las Vegas April 15-18, 2027, the event built around the business, legal, and financial side of running a med spa rather than the clinical one. Ownership structure, compliance, and profitability are the agenda, which makes it the most directly relevant aesthetics conference for an owner watching the P&L. Sorso is not an exhibitor, sponsor, or speaker at this event. This is an independent prep guide for med spa owners and operators.
The CFO read
Most aesthetics conferences sell equipment or growth tactics. AmSpa's show is the one built around the parts of a med spa that decide whether it is legal and whether it makes money: how you are structured, how you stay compliant, and where the margin actually comes from. For an owner, that is the more valuable trip, because a structural or compliance mistake costs more than any device on a show floor. Before Las Vegas, get clear on two things: whether your ownership and medical director structure holds up in your state, and which of your services actually carry the practice. The sessions land harder when you already know your own numbers.
— Stanislav Sukhinin, CFA · Founder, Sorso
Why this matters for your bottom line
AmSpa's event is organized around the questions that decide whether a med spa is compliant and profitable: who can legally own it, how the medical director relationship is structured, and how the entity is set up. Those decisions sit upstream of every financial result.
Ownership and management structures in aesthetics vary by state and carry real tax and liability consequences. A structure that was fine at one location can become a problem as you add sites or partners.
Med spa profitability is a service-mix question. The treatments that fill the schedule are not always the ones that carry the margin, and owners who track profit per service make different decisions than owners who track revenue.
Injectable and device pricing pressure keeps rising as competition grows. Knowing your cost per treatment and your provider productivity is what lets you hold margin without chasing competitors down on price.
What to look for
Sessions on ownership and management structure, including MSO models and medical director agreements, with the state-specific compliance rules
Compliance content that carries direct financial consequences: good-standing requirements, scope of practice, and supervision rules
Profitability sessions that break down margin by service line rather than total revenue
Membership and package pricing models, evaluated on patient lifetime value and retention
Provider compensation and productivity structures that align pay with the margin each provider generates
Financial prep checklist
Review these before you go.
Map profit margin by treatment type, including product cost, room time, and provider time, not just the price
Confirm your ownership and medical director structure against your state's current requirements before you invest in growth
Run provider productivity: revenue and margin per provider hour for each injector and aesthetician
Estimate patient acquisition cost by channel and lifetime value by service line
Review membership and package economics: retention rate and the margin each plan actually contributes
Inventory device and injectable costs and calculate the break-even volume for each major line
What it costs to send someone
Registration is the line everyone budgets first. It is rarely the one that decides whether the trip was worth it.
Registration
AmSpa has not posted 2027 rates, but the show site already tells you the best pricing is available now, which is the organizer saying the rate goes up the longer you wait. Decide early or plan to pay the later band.
Coverage and lost production
If you inject, four days at the Wynn is four days of treatment revenue you do not book, and that number is knowable: take your average revenue per injector day and multiply by four. For a single-injector spa that line is the trip. Run it before you decide how many days to be away.
Who else travels
Most owners bring the practice manager and at least one injector, and they should. The compliance and ownership-structure sessions are wasted if only one person hears them. Just cost the extra treatment days, not only the extra flights.
What comes back as a deduction
IRS Publication 463 allows the travel deduction for a convention where “your attendance benefits your trade or business,” on the ordinary rules for travel away from home. Meals are generally limited to 50% of the unreimbursed cost. Keep the agenda with the receipts, and confirm the treatment with whoever signs your return.
No rates are quoted here. The organizer had published none when we last checked this page against their site on 10 August 2026, and travel is yours to price for your own dates anyway. The point of the list is that the two lines owners leave out, coverage and headcount, are the ones that decide the real number.
Before Medical Spa Show 2027, get your own numbers straight
Walk in able to check every benchmark on the slides against your own numbers. Three ways owners start with us:
Med Spa Accounting & CFO
Built for med spa economics
Injectable and device margins, membership revenue, and cash-pay mix — for med spa owners. From $2,000/mo.
Explore your specialty →Accounting
Healthcare-specialist accounting
Books done right by people who understand clinic finance. Starts at $2,000/mo.
Explore Accounting →Free Assessment
A financial checkup before you go
Four minutes. See where your practice stands so every session is measured against your own numbers.
Take the assessment →Going to Medical Spa Show 2027?
Tell us, and we will look at coming to meet you.
Stan does not have a ticket booked for this one yet. If enough clinic owners want to sit down there, that is what decides it. Register interest and we will confirm either way well before the dates — no obligation, and we will not add you to a mailing list.
Register interest in meeting →
Founder of Sorso and a CFA charterholder. Before Sorso, Stan spent 19 years in corporate finance at institutions including UniCredit and Société Générale — managing a $450M loan portfolio and making senior partner at a major mezzanine lender by 29 — then built a fractional CFO firm exclusively for outpatient healthcare clinics.